Skip to Main Content

Paper Details

Identification of six new susceptibility loci for invasive epithelial ovarian cancer.
Nat Genet
176
2015
17q11, 1p34, 1p36, 4q26, 6p22, 9q34, ABO, ATAD5, BRCA1, BRCA1 mutation, BRCA2, BRCA2 mutation, EOC, GPX6, GPX6) variants, RSPO1, SYNPO2, WNT4, epithelial ovarian cancer, invasive epithelial ovarian cancer, ovarian cancer, serous EOC subtype, susceptibility loci
Author NameAffiliation
Susan J RamusKeck School of Medicine, University of Southern California Norris Comprehensive Cancer Center
Susan J RamusKeck School of Medicine, University of Southern California Norris Comprehensive Cancer Center
Jonathan TyrerUniversity of Cambridge
Jonathan BeesleyQIMR Berghofer Medical Research Institute
Jonathan BeesleyQIMR Berghofer Medical Research Institute
Sue HealeyQIMR Berghofer Medical Research Institute
Sue HealeyQIMR Berghofer Medical Research Institute
Tanja PejovicOregon Health and Science University, USA. [2] Knight Cancer Institute
Yukie BeanOregon Health and Science University, USA. [2] Knight Cancer Institute
Qiyuan LiCenter for Functional Cancer Epigenetics, Dana-Farber Cancer Institute
Simon G CoetzeeRibeirao Preto Medical School, University of Sao Paulo, Brazil. [2] Center for Cell-Based Therapy, Brazil. [3] Center for Integrative Systems Biology
Mary Beth TerryColumbia University
David E GoldgarUniversity of Utah School of Medicine
David E GoldgarUniversity of Utah School of Medicine
Javier Ben??tezSpanish National Cancer Centre (CNIO)
Ana OsorioSpanish National Cancer Centre (CNIO)
Mar??a J Garc??aSpanish National Cancer Centre (CNIO)
Ian K KomenakaMaricopa Medical Center, care of City of Hope Clinical Cancer Genetics Community Research Network
Siranoush ManoukianFondazione IRCCS (Istituto di Ricovero e Cura a Carattere Scientifico (Italian Research Hospital)) Istituto Nazionale Tumori (INT)
Paolo RadiceFondazione IRCCS Istituto Nazionale Tumori (INT)
Judy E GarberCancer Risk and Prevention Clinic, Dana-Farber Cancer Institute
Judy Kirk
Gustavo C RodriguezNorthShore University HealthSystem
Ian G CampbellPeter MacCallum Cancer Centre
Jacek GronwaldPomeranian Medical University
Jacek GronwaldPomeranian Medical University
Jan LubinskiPomeranian Medical University
Jan LubinskiPomeranian Medical University
Noralane M LindorMayo Clinic
Noralane M LindorMayo Clinic
Irene L AndrulisUniversity of Toronto
Irene L AndrulisUniversity of Toronto
Robert L NussbaumUniversity of California san francisco
Timothy R RebbeckAbramson Cancer Center, Perelman School of Medicine, University of Pennsylvania
Katherine L NathansonAbramson Cancer Center, Perelman School of Medicine, University of Pennsylvania
Susan M DomchekAbramson Cancer Center, Perelman School of Medicine, University of Pennsylvania
Beth Y KarlanWomen's Cancer Program at the Samuel Oschin Comprehensive Cancer Institute, Cedars-Sinai Medical Center
Jenny LesterWomen's Cancer Program at the Samuel Oschin Comprehensive Cancer Institute, Cedars-Sinai Medical Center
Peter A FaschingErlangen University Hospital, University of Erlangen-Nuremberg, David Geffen School of Medicine, University of California los angeles
Diether Lambrechts1] Vesalius Research Center, University of Leuven
Jennifer A DohertyGeisel School of Medicine at Dartmouth
Jennifer A DohertyGeisel School of Medicine at Dartmouth
Mary Anne RossingFred Hutchinson Cancer Research Center, University of Washington
Jenny Chang-ClaudeGerman Cancer Research Center (DKFZ)
Lara E Sucheston-CampbellRoswell Park Cancer Institute
Lynne R WilkensUniversity of Hawaii Cancer Center
Lynne R WilkensUniversity of Hawaii Cancer Center
Marc T GoodmanSamuel Oschin Comprehensive Cancer Institute, Cedars-Sinai Medical Center, USA. [2] Community and Population Health Research Institute
Pamela J ThompsonSamuel Oschin Comprehensive Cancer Institute, Cedars-Sinai Medical Center, USA. [2] Community and Population Health Research Institute
Andreas du Bois
  • 1 - 50

Datasets